Accenture Life Sciences Blog
Pharmaceutical and medical technology companies face both complexity and opportunity when navigating the current healthcare landscape. Accenture experts will share their insights and opinions on how pharmaceutical and medical technology companies can rethink, reshape and restructure for better patient outcomes during complex times.
 
 
Our latest Biopharmaceutical High Performance Business Study shows some positive signs that the industry is pivoting to the patient. While the science-based strategies of high-performing life sciences companies are a key contributor to this positive...
 
 
 
 
Leading digital life sciences companies have recognized that technology is the driving force not only for how they develop products, but also for how they go to market, how they collaborate with payers and providers, and even how they engage patient...
 
 
 
 
High-performing biopharma companies are translating innovative new science into higher growth and outperforming the market on three key forward-looking metrics I shared last week. These companies have been able to bring new products to market by dem...
 
 
 
 
The life sciences industry faces a new set of issues potentially affecting existing business models, in the form of major ongoing changes to healthcare systems in North America and Europe. In Accenture’s 2013 Global Risk Management Study, ...
 
 
 
 
Since our 2012 study on high performance biopharma companies, there has been continued improvement in the pharma sector and increased confidence among investors. Evidence of this recovery is clear in some of the findings I shared with you last week....
 
 
 
 
In general, life sciences companies are more confident in their capabilities to deal with R&D pipeline risks than supply chain and joint partner risks, according to Accenture’s 2013 Global Risk Management Study. Nearly 60 percent of surveye...
 
 
 
 
We are in interesting times in the life sciences industry. Amidst the turmoil of reimbursement requirement changes in all major markets, the rise of China to the second largest market in the world, digital disruption to operating models and the cont...
 
 
 
 
While there may be a gap between where life sciences companies see their current risk management capabilities and where they need to be, the good news is most executives are relatively confident in their ability to address key issues facing the indu...
 
 
 
 
There’s a measurable gap between the maturity of life sciences companies’ current risk management capabilities and their perceived future need for these capabilities—this, one of the most notable findings from the Accenture 2013 Global Risk Manageme...
 
 
 
 
According to our recent Global Risk Management Study, life sciences companies see legal and market risks as the most likely to rise over the next two years. So, what are they doing to manage these emerging risks? Increasingly, life sciences comp...
 
 
 Next >>
About the Authors
Anne O'Riordan
Anne O'Riordan is global managing director of Accenture Lif...
 

Photo of Jeffrey Russell

Jeffrey Russell is managing director of Accenture Life Sciences in North America.

Russell has more than 20 years of exper...
 
Doug Mowen
Doug Mowen is the managing director for Accenture’s Medical Technology Practice. With 25 years of experience and 15 years serving th...
 
Photo of David Boath
David Boath is managing director of Accenture Life Sciences Research and Development.

Boath has worked with num...
 
Photo Of Hussain Mooraj
Hussain Mooraj, managing director of Accenture Life Sciences Supply Chain, works with companies across the healthcare value chain to...
 
Photo of Henry Levy
Henry Levy is the managing director of Accenture Life Sciences Research and Development.

Levy has 20 years of experience wit...
 
Jeff Elton
Jeff Elton, managing director of Accenture Life Sciences, has broad responsibilities for the strategy and partnerships for ne...
 
Managing Director, Accenture Life Sciences, Technology Lead
Sunil Rao is Global Managing Director, Accenture Life Sciences,...
 
Shawn Roman
Shawn Roman is a managing director in Accenture Life Sciences and leads the North America Commercial Services practice. Mr. Roman h...
 
 

 

By using this site you agree that we can place cookies on your device. See our privacy statement for details.